{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:48:23Z","timestamp":1782895703412,"version":"3.54.5"},"reference-count":102,"publisher":"Termedia Sp. z.o.o.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pol J Radiol"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Breast cancer heterogeneity is crucial for treatment decision-making and prognosis prediction. Magnetic resonance imaging (MRI) is a\u00a0key tool in breast imaging, providing a\u00a0non-invasive assessment of\u00a0morphological characteristics, cell density, hemodynamics, and vascular proliferation. Integrating MRI with advanced techniques such as radiomics, habitat imaging, and artificial intelligence enables a\u00a0deeper understanding of\u00a0tumor morphology and biological behavior through analysis of\u00a0imaging features, thereby characterizing the\u00a0heterogeneity inherent in breast cancer. This review explores MRI\u2019s role as an imaging biomarker for evaluating breast cancer molecular subtypes, aiming to support personalized treatment strategies and improve therapeutic outcomes.<\/jats:p>","DOI":"10.5114\/pjr\/216424","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:20:11Z","timestamp":1782894011000},"page":"288-298","source":"Crossref","is-referenced-by-count":0,"title":["The\u00a0role of\u00a0magnetic resonance imaging (MRI) in breast cancer molecular subtypes"],"prefix":"10.5114","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5905-2636","authenticated-orcid":true,"given":"Run","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"ref-1918235","doi-asserted-by":"crossref","unstructured":"L\u00fc\u00f6nd F, Tiede S, Christofori G. Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression. Br J Cancer 2021; 125: 164-175.","DOI":"10.1038\/s41416-021-01328-7"},{"key":"ref-1918236","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00247-3"},{"key":"ref-1918237","doi-asserted-by":"crossref","unstructured":"Ao F, Yan Y, Zhang ZL, Li S, Li WJ, Chen GB. The value of dyna\u00admic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast. Acta Radiol 2021; 63: 891-900.","DOI":"10.1177\/02841851211024002"},{"key":"ref-1918238","doi-asserted-by":"crossref","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, Cook G. Introduction to radiomics. J Nucl Med 2020; 61: 488-495.","DOI":"10.2967\/jnumed.118.222893"},{"key":"ref-1918239","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4970265"},{"key":"ref-1918240","doi-asserted-by":"crossref","unstructured":"Parekh VS, Jacobs MA. Multiparametric radiomics methods for breast cancer tissue characterization using radiological imaging. Breast Cancer Res Treat 2020; 180: 407-421.","DOI":"10.1007\/s10549-020-05533-5"},{"key":"ref-1918241","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1307907"},{"key":"ref-1918242","doi-asserted-by":"crossref","unstructured":"Kim JY, Kim JJ, Hwangbo L, Lee JW, Lee NK, Nam KJ, et al. Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk. Eur Radiol 2020; 30: 66-76.","DOI":"10.1007\/s00330-019-06383-6"},{"key":"ref-1918243","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092159"},{"key":"ref-1918244","doi-asserted-by":"publisher","DOI":"10.3390\/cancers-14071837"},{"key":"ref-1918245","doi-asserted-by":"crossref","unstructured":"Jeibouei S, Akbari M E, Kalbasi A, Aref AR, Ajoudanian M, Rezvani A, Zali H. Personalized medicine in breast cancer: pharmacogenomics approaches. Pharmacogenomics Pers Med 2019; 12: 59-73.","DOI":"10.2147\/PGPM.S167886"},{"key":"ref-1918246","doi-asserted-by":"crossref","unstructured":"Ram\u00f3n Y Cajal S, Ses\u00e9 M, Capdevila C, Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, et al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl) 2020; 98: 161-177.","DOI":"10.1007\/s00109-020-01874-2"},{"key":"ref-1918247","doi-asserted-by":"crossref","unstructured":"Vitale I, Shema E, Loi S, Galluzzi L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat Med 2021; 27: 212-224.","DOI":"10.1038\/s41591-021-01233-9"},{"key":"ref-1918248","doi-asserted-by":"crossref","unstructured":"Tendl KA, Bago-Horvath Z. Molecular profiling in breast cancer \u2013 ready for clinical routine? memo \u2013 Magazine of European Medical Oncology 2020; 13: 445-449.","DOI":"10.1007\/s12254-020-00578-0"},{"key":"ref-1918249","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2023.121371"},{"key":"ref-1918250","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-01130-2"},{"key":"ref-1918251","doi-asserted-by":"crossref","unstructured":"Stevanovic L, Choschzick M, Moskovszky L, Varga Z. Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015-2018. J Cancer Res Clin Oncol 2019; 145: 2983-2994.","DOI":"10.1007\/s00432-019-03057-0"},{"key":"ref-1918252","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1132186"},{"key":"ref-1918253","doi-asserted-by":"crossref","unstructured":"Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 2007; 74: 72-84.","DOI":"10.1016\/j.mvr.2007.05.003"},{"key":"ref-1918254","doi-asserted-by":"crossref","unstructured":"Leithner D, Wengert GJ, Helbich TH, Thakur S, Ochoa-Albiztegui RE, Morris EA, Pinker K. Clinical role of breast MRI now and going forward. Clin Radiol 2018; 73: 700-714.","DOI":"10.1016\/j.crad.2017.10.021"},{"key":"ref-1918255","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7984591"},{"key":"ref-1918256","doi-asserted-by":"crossref","unstructured":"Karavas E, Ece B, Ayd\u0131n S. Type 2 dynamic curves: a diagnostic dilemma. World J Radiol 2022; 14: 229-237.","DOI":"10.4329\/wjr.v14.i7.229"},{"key":"ref-1918257","doi-asserted-by":"publisher","DOI":"10.1259\/bjro.20220002"},{"key":"ref-1918258","unstructured":"Seyfettin A, Dede I, Hakverdi S, D\u00fczel As\u0131g B, Temiz M, Karazincir S. MR imaging properties of breast cancer molecular subtypes. Eur Rev Med Pharmacol Sci 2022; 26: 3840-3848."},{"key":"ref-1918259","doi-asserted-by":"crossref","unstructured":"Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, et al. Background, current role, and potential applications of radio\u00adgenomics. J Magn Reson Imaging 2017; 47: 604-620.","DOI":"10.1002\/jmri.25870"},{"key":"ref-1918260","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-020-0167-x"},{"key":"ref-1918261","doi-asserted-by":"crossref","unstructured":"Tuan Linh L, Minh Duc N, Tra My TT, Viet Bang L, Minh Pham T. Correlations between dynamic contrast-enhanced magnetic reso\u00adnance imaging parameters and histopathologic factors in breast cancer. Clin Ter 2021; 172: 453-460.","DOI":"10.1530\/EDM-20-0220"},{"key":"ref-1918262","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics-10121090"},{"key":"ref-1918263","doi-asserted-by":"crossref","unstructured":"Du S, Gao S, Zhang L, Yang X, Qi X, Li S. Improved discrimination of molecular subtypes in invasive breast cancer: comparison of multiple quantitative parameters from breast MRI. Magn Reson Imaging 2021; 77: 148-158.","DOI":"10.1016\/j.mri.2020.12.001"},{"key":"ref-1918264","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2019.12.023"},{"key":"ref-1918265","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-022-00499-7"},{"key":"ref-1918266","doi-asserted-by":"publisher","DOI":"10.3390\/life12040490"},{"key":"ref-1918267","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4623850"},{"key":"ref-1918268","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028109"},{"key":"ref-1918269","doi-asserted-by":"crossref","unstructured":"Cheng X, Chen C, Xia H, Zhang L, Xu M. 3.0 T magnetic resonance functional imaging quantitative parameters for differential diagnosis of benign and lesions of the breast. Cancer Biother Radiopharm 2021; 36: 448-455.","DOI":"10.1089\/cbr.2019.3040"},{"key":"ref-1918270","doi-asserted-by":"crossref","unstructured":"Setiawan K, Suryawisesa IB, Widiana IK, Sudarsa IW. Does a 40% cut-off point for ki-67 expression have a role in identifying the development of distant metastasis within 2 years in locally advanced triple negative breast cancer patients? Eur J Breast Health 2023; 19: 274-278.","DOI":"10.4274\/ejbh.galenos.2023.2023-4-5"},{"key":"ref-1918271","doi-asserted-by":"crossref","unstructured":"Li A, Pan Y, Chen B, Huang R, Xia J, Jin Y, Zheng J. Evaluation of quantitative dynamic contrast-enhanced (DCE)-MRI parameters using a reference region model in invasive ductal carcinoma (IDC) patients. Int J Imaging Syst Technol 2021; 31: 215-222.","DOI":"10.1002\/ima.22454"},{"key":"ref-1918272","doi-asserted-by":"crossref","unstructured":"Tezcan S, Ozturk FU, Uslu N, Akcay EY. The role of combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating malignant from benign breast lesions presenting washout curve. Can Assoc Radiol J 2021; 72: 460-469.","DOI":"10.1177\/0846537120907098"},{"key":"ref-1918273","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01147"},{"key":"ref-1918274","doi-asserted-by":"crossref","unstructured":"Kataoka M, Honda M, Ohashi A, Yamaguchi K, Mori N, Goto M, et al. Ultrafast dynamic contrast-enhanced MRI of the breast: how is it used? Magn Reson Med Sci 2022; 21: 83-94.","DOI":"10.2463\/mrms.rev.2021-0157"},{"key":"ref-1918275","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108984"},{"key":"ref-1918276","doi-asserted-by":"crossref","unstructured":"Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S, et al. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. J Magn Reson Imaging 2019; 51: 164-174.","DOI":"10.1002\/jmri.26838"},{"key":"ref-1918277","doi-asserted-by":"crossref","unstructured":"Onishi N, Sadinski M, Gibbs P, Gallagher KM, Hughes MC, Ko ES, et al. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI. Eur Radiol 2019; 30: 756-766.","DOI":"10.1007\/s00330-019-06392-5"},{"key":"ref-1918278","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01292-9"},{"key":"ref-1918279","doi-asserted-by":"crossref","unstructured":"Goto M, Sakai K, Yokota H, Kiba M, Yoshida M, Imai H, et al. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions. Eur Radiol 2018; 29: 1164-1174.","DOI":"10.1007\/s00330-018-5643-4"},{"key":"ref-1918280","doi-asserted-by":"crossref","unstructured":"Yamaguchi K, Nakazono T, Egashira R, Fukui S, Baba K, Hama\u00admoto T, Irie H. Maximum slope of ultrafast dynamic contrast-enhanced MRI of the breast: comparisons with prognostic factors of breast cancer. Jpn J Radiol 2020; 39: 246-253.","DOI":"10.1007\/s11604-020-01049-6"},{"key":"ref-1918281","doi-asserted-by":"crossref","unstructured":"Zhang M, Horvat J V, Bernard-Davila B, Marino MA, Leithner D, Ochoa-Albiztegui RE, et al. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy. J Magn Reson Imaging 2019; 49: 864-874.","DOI":"10.1002\/jmri.26285"},{"key":"ref-1918282","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00332"},{"key":"ref-1918283","doi-asserted-by":"crossref","unstructured":"Goto M, Le Bihan D, Sakai K, Yamada K. The diffusion MRI signature index is highly correlated with immunohistochemical status and molecular subtype of invasive breast carcinoma. Eur Radiol 2022; 32: 4879-4888.","DOI":"10.1007\/s00330-022-08562-4"},{"key":"ref-1918284","doi-asserted-by":"crossref","unstructured":"Rupa R, Thushara R, Swathigha S, Athira R, Meena N, Cherian MP. Diffusion weighted imaging in breast cancer \u2013 can it be a noninvasive predictor of nuclear grade? Indian J Radiol Imaging 2020; 30: 13-19.","DOI":"10.4103\/ijri.IJRI_97_19"},{"key":"ref-1918285","doi-asserted-by":"crossref","unstructured":"Meyer H J, Wienke A, Surov A. Diffusion-weighted imaging of different breast cancer molecular subtypes: a systematic review and meta-analysis. Breast Care (Basel) 2022; 17: 47-54.","DOI":"10.1159\/000514407"},{"key":"ref-1918286","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111124"},{"key":"ref-1918287","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061493"},{"key":"ref-1918288","doi-asserted-by":"crossref","unstructured":"Horvat JV, Bernard-Davila B, Helbich TH, Zhang M, Morris EA, Thakur SB, et al. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer. J Magn Reson Imaging 2019; 50: 836-846.","DOI":"10.1002\/jmri.26697"},{"key":"ref-1918289","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031574"},{"key":"ref-1918290","doi-asserted-by":"crossref","unstructured":"Yao FF, Zhang Y. A review of quantitative diffusion-weighted MR imaging for breast cancer: towards noninvasive biomarker. Clin Imaging 2023; 98: 36-58.","DOI":"10.1016\/j.clinimag.2023.03.016"},{"key":"ref-1918291","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1139189"},{"key":"ref-1918292","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.585486"},{"key":"ref-1918293","doi-asserted-by":"crossref","unstructured":"Meng N, Wang X J, Sun J, Huang L, Wang Z, Wang KY, et al. Comparative study of amide proton transfer-weighted imaging and intravoxel incoherent motion imaging in breast cancer diagnosis and evaluation. J Magn Reson Imaging 2020; 52: 1175-1186.","DOI":"10.1002\/jmri.27190"},{"key":"ref-1918294","doi-asserted-by":"crossref","unstructured":"Uslu H, \u00d6nal T, Tosun M, Arslan AS, Ciftci E, Utkan NZ. Intravoxel incoherent motion magnetic resonance imaging for breast cancer: a comparison with molecular subtypes and histological grades. Magn Reson Imaging 2021; 78: 35-41.","DOI":"10.1016\/j.mri.2021.02.005"},{"key":"ref-1918295","unstructured":"Ma Y, Shan D, Wei J, Chen A. Application of intravoxel incoherent motion diffusion-weighted imaging in differential diagnosis and molecular subtype analysis of breast cancer. Am J Transl Res 2021; 13: 3034-3043."},{"key":"ref-1918296","doi-asserted-by":"publisher","DOI":"10.1259\/bjro.20220038"},{"key":"ref-1918297","doi-asserted-by":"crossref","unstructured":"Zhang J, Chen Y, Zhang E, Li N, Yuan H, Lang N. Use of mono\u00adexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors. Eur Spine J 2020; 29: 1112-1120.","DOI":"10.1007\/s00586-020-06330-w"},{"key":"ref-1918298","doi-asserted-by":"crossref","unstructured":"Zhang J, Xing X, Wang Q, Chen Y, Yuan H, Lang N. Preliminary study of monoexponential, biexponential, and stretched-exponential models of diffusion-weighted MRI and diffusion kurtosis imaging on differential diagnosis of spinal metastases and chordoma. Eur Spine J 2022; 31: 3130-3138.","DOI":"10.1007\/s00586-022-07269-w"},{"key":"ref-1918299","doi-asserted-by":"crossref","unstructured":"Zhou WP, Zan XY, Hu XY, Liu X, Sudarshan SKP, Yang SD, et al. Characterization of breast lesions using diffusion kurtosis model-based imaging: an initial experience. J Xray Sci Technol 2020; 28: 157-169.","DOI":"10.3233\/XST-190590"},{"key":"ref-1918300","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.110014"},{"key":"ref-1918301","doi-asserted-by":"crossref","unstructured":"Meng N, Wang X, Sun J, Han D, Bai Y, Wei W, et al. A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer. Eur Radiol 2020; 31: 1707-1717.","DOI":"10.1007\/s00330-020-07169-x"},{"key":"ref-1918302","doi-asserted-by":"crossref","unstructured":"Huang Y, Lin Y, Hu W, Ma C, Lin W, Wang Z, et al. Diffusion curtosis at 3.0T as an in vivo imaging marker for breast cancer characte\u00adrization: correlation with prognostic factors. J Magn Reson Imaging 2019; 49: 845-856.","DOI":"10.1002\/jmri.26249"},{"key":"ref-1918303","doi-asserted-by":"crossref","unstructured":"Kang HS, Kim JY, Kim JJ, Kim S, Lee NK, Lee JW, et al. Diffusion kurtosis MR imaging of invasive breast cancer: correlations with prognostic factors and molecular subtypes. J Magn Reson Imaging 2022; 56: 110-120.","DOI":"10.1002\/jmri.27999"},{"key":"ref-1918304","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1911-6"},{"key":"ref-1918305","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45079-2"},{"key":"ref-1918306","doi-asserted-by":"crossref","unstructured":"Gao W, Zhang S, Guo J, Wei X, Li X, Diao Y, et al. Investigation of synthetic relaxometry and diffusion measures in the differentiation of benign and malignant breast lesions as compared to BI-RADS. J Magn Reson Imaging 2020; 53: 1118-1127.","DOI":"10.1002\/jmri.27435"},{"key":"ref-1918307","doi-asserted-by":"crossref","unstructured":"Matsuda M, Tsuda T, Ebihara R, Toshimori W, Takeda S, Okada K, et al. Enhanced masses on contrast-enhanced breast: differentiation using a combination of dynamic contrast-enhanced MRI and quantitative evaluation with synthetic MRI. J Magn Reson Imaging 2020; 53: 381-391.","DOI":"10.1002\/jmri.27362"},{"key":"ref-1918308","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.699127"},{"key":"ref-1918309","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109697"},{"key":"ref-1918310","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110168"},{"key":"ref-1918311","doi-asserted-by":"crossref","unstructured":"Yuen S, Monzawa S, Yanai S, Matsumoto H, Yata Y, Ichinose Y, et al. The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images. Breast Cancer 2020; 27: 1029-1037.","DOI":"10.1007\/s12282-020-01105-z"},{"key":"ref-1918312","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2023.10.015"},{"key":"ref-1918313","doi-asserted-by":"crossref","unstructured":"Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology 2021; 298: 505-516.","DOI":"10.1148\/radiol.2021202553"},{"key":"ref-1918314","doi-asserted-by":"crossref","unstructured":"Lafc\u0131 O, Celepli P, Seher \u00d6ztekin P, Ko\u015far PN. DCE-MRI radiomics analysis in differentiating luminal A and luminal B breast cancer molecular subtypes. Acad Radiol 2022; 30: 22-29.","DOI":"10.1016\/j.acra.2022.04.004"},{"key":"ref-1918315","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30010-6"},{"key":"ref-1918316","doi-asserted-by":"crossref","unstructured":"Xie T, Zhao Q, Fu C, Bai Q, Zhou X, Li L, et al. Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging. Eur Radiol 2019; 29: 2535-2544.","DOI":"10.1007\/s00330-018-5804-5"},{"key":"ref-1918317","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.110055"},{"key":"ref-1918318","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-020-00887-2"},{"key":"ref-1918319","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9623173"},{"key":"ref-1918320","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1187-z"},{"key":"ref-1918321","doi-asserted-by":"crossref","unstructured":"Leithner D, Bernard-Davila B, Martinez DF, Horvat JV, Jochelson MS, Marino MA, et al. Radiomic signatures derived from diffusion-weighted imaging for the assessment of breast cancer receptor status and molecular subtypes. Mol Imaging Biol 2020; 22: 453-461.","DOI":"10.1007\/s11307-019-01383-w"},{"key":"ref-1918322","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2972189"},{"key":"ref-1918323","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09932-5"},{"key":"ref-1918324","doi-asserted-by":"crossref","unstructured":"Gillies RJ, Balagurunathan Y. Perfusion MR imaging of breast cancer: insights using \u201chabitat imaging\u201d. Radiology 2018; 288: 36-37.","DOI":"10.1148\/radiol.2018180271"},{"key":"ref-1918325","doi-asserted-by":"crossref","unstructured":"Kim JJ, Kim JY, Suh HB, Hwangbo L, Lee NK, Kim S, et al. Charac\u00adterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging. Eur Radiol 2022; 32: 822-833.","DOI":"10.1007\/s00330-021-08166-4"},{"key":"ref-1918326","doi-asserted-by":"crossref","unstructured":"Kim M, Park JE, Kim HS, Kim N, Park SY, Kim YH, Kim JH, et al. Spatiotemporal habitats from multiparametric physiologic MRI distinguish tumor progression from treatment-related change in post-treatment glioblastoma. Eur Radiol 2021; 31: 6374-6383.","DOI":"10.1007\/s00330-021-07718-y"},{"key":"ref-1918327","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081858"},{"key":"ref-1918328","doi-asserted-by":"crossref","unstructured":"Zhang L, Fan M, Wang S, Xu M, Li L. Radiomic analysis of pharmacokinetic heterogeneity within tumor based on the unsupervised decomposition of dynamic contrast-enhanced MRI for predicting histological characteristics of breast cancer. J Magn Reson Imaging 2022; 55: 1636-1647.","DOI":"10.1002\/jmri.27993"},{"key":"ref-1918329","doi-asserted-by":"crossref","unstructured":"Wang H, Zeng L, Wu H, Tian J, Xie H, Zhang L, et al. Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas. Eur Radiol 2024; 34: 1982-1993.","DOI":"10.1007\/s00330-023-10149-6"},{"key":"ref-1918330","doi-asserted-by":"crossref","unstructured":"Feng S, Yin J. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer. Quant Imaging Med Surg 2023; 13: 6735-6749.","DOI":"10.21037\/qims-22-1073"},{"key":"ref-1918331","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00543"},{"key":"ref-1918332","doi-asserted-by":"crossref","unstructured":"Xu R, Yu D, Luo P, Li X, Jiang L, Chang S, Li G. Do habitat MRI and fractal analysis help distinguish triple-negative breast cancer from non-triple-negative breast carcinoma. Can Assoc Radiol J 2024; 75: 584-592.","DOI":"10.1177\/08465371241231573"},{"key":"ref-1918333","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2024.110305"},{"key":"ref-1918334","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240184"},{"key":"ref-1918335","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2024.03.006"},{"key":"ref-1918336","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-024-01713-9"}],"container-title":["Polish Journal of Radiology"],"original-title":[],"link":[{"URL":"https:\/\/www.polradiol.com\/pdf-216424-141911","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.polradiol.com\/pdf-216424-141911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:23:12Z","timestamp":1782894192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.polradiol.com\/The-role-of-magnetic-resonance-imaging-MRI-in-breast-cancer-molecular-subtypes,216424,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["216424"],"URL":"https:\/\/doi.org\/10.5114\/pjr\/216424","relation":{},"ISSN":["1899-0967"],"issn-type":[{"value":"1899-0967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}